Task C1: Phase I Clinical Trial to Evaluate Influenza Therapeutics

NIH RePORTER · NIH · N01 · $3,205,231 · view on reporter.nih.gov ↗

Abstract

The Early Phase Clinical Trial Units provide a vehicle for investigation of new agents in the treatment and prevention of infectious diseases and can carry out all aspects of interventional clinical trial implementation.

Key facts

NIH application ID: 11202303
Project number: 75N93022D00015-0-759302400001-1
Recipient: ALLUCENT GOVERNMENT SERVICES (US) LLC
Principal Investigator: MCCLENATHAN BRUCE
Activity code: N01
Funding institute: NIH
Fiscal year: 2024
Award amount: $3,205,231
Award type: —
Project period: 2024-08-15 → 2024-11-01